RyboDyn

Decrypting the dark proteome

San Diego, United States · Founded 2022 · $14.3M raised

Headquarters
San Diego
Employees
1–10
Founded
2022
Total Funding
$14.3M
Last Round
$10.0M SeedMar 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

RyboDyn is a biotechnology company pioneering immunotherapy development by unlocking the dark proteome through its proprietary RyboCypher™ platform, which fuses novel RNA sequencing with AI models to predict proteins encoded by non-coding RNAs. The company transforms these hidden Cryptic Targets™ into antibody-based drug candidates for next-generation cancer immunotherapies.

Summary

RyboDyn is a Biotech company based in San Diego, United States, founded in 2022. It has raised $14.3M in total across 3 rounds, most recently a $10.0M Seed round in Mar 2026. Investors include Genedant Capital, SeaX Ventures and SOSV.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMar 2026
$10.0M

Sign up to see all 3 events

Funding: Pre-Seed through Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

RyboDyn on Indexed.vc
<a href="https://indexed.vc/companies/rybodyn"><img src="https://indexed.vc/api/badge/company/rybodyn" alt="RyboDyn on Indexed.vc" width="260" height="76" /></a>